Rocket Lab Beats on Revenue but Still Posts a Loss, and Its Iridium Deal Clears a Vote
Rocket Lab reported third-quarter 2026 revenue of $267.83 million, ahead of a consensus estimate of $255.71 million, and a loss of 12 cents per share, according to Benzinga. Consensus is the average of analyst forecasts, so a beat means sales came in above what the analysts expected. The top-line beat works out to about $12.1 million, or roughly 4.7 percent above the estimate.
The company had flagged the timing of the release earlier in the quarter. An October 20, 2026 notice on the investor relations site announced the date of the third-quarter results, which is the standard pre-announcement for a company that reports on a fixed calendar.
A revenue beat paired with a per-share loss is a familiar combination in growth-stage space and launch businesses. Revenue is the money customers paid in. A loss per share means costs, depreciation (the gradual writing-down of expensive equipment over its working life), or non-operating items still outran it for the period. Which of those is driving the gap matters a great deal for how the quarter should be read, and that is where a careful analyst will want the full income statement rather than the headline pair. The market's reaction will likely turn on whether management can show a path from revenue growth to positive earnings, not on the beat itself.
The second thread is the pending Iridium transaction. On September 24, 2026, Rocket Lab announced that Iridium stockholders approved the acquisition of Iridium by Rocket Lab. According to the same announcement, Iridium stockholders will receive $27.00 in cash in connection with the deal, and the transaction carries a notional value of $54.00 per share of Iridium common stock.
Notional value is a headline figure that a deal's parties attach to the consideration. It is not a measure of what each holder actually receives in cash. Think of it as a price tag that adds up the whole package, not just the money in your hand. Here the cash component is half the notional figure. The other half is set out in the announcement's full text and any subsequent filings, and a holder's real economics depend on those terms rather than on the $54.00 figure alone. Anyone modeling the position should work from the stated per-share terms, not from the headline.
For an Iridium holder, the cash line is the number that can be marked against the announced terms. For a Rocket Lab shareholder, the more relevant question is how a transaction of this size will be funded and what it will do to the balance sheet. Neither should be assumed.
Where that leaves things: Rocket Lab's quarter came in above the revenue consensus while still posting a loss, and the Iridium deal has cleared the stockholder vote with a stated $27.00 cash payment and a $54.00 notional value per share. Everything beyond those points belongs to the filings and the next earnings call, where the detailed reader will find the margin, cash, and financing information that the headlines leave out.
